FERTILLIKNI SAQLASH DASTURLARINING ONKOLOGIK KASALLIKLARGA CHALINGAN AYOLLARNING HAYOT SIFATIGA TA'SIRI
##article.subject##:
saraton, fertillikni saqlash, prognoz, hayot sifati##article.abstract##
Tadqiqot tug'ilishni saqlash dasturlarining saraton kasalligiga chalingan ayollarning hayot sifatiga ta'sirini o'rganib chiqdi. Ishtirok etgan 140 nafar bemor ikki guruhga bo'lingan: asosiy guruh (75 nafar tug'ilishni saqlash dasturidan o'tgan ayollar) va nazorat guruhi (bunday dasturlarda ishtirok etmagan 65 nafar ayol). Hayot sifati FertiQOL so'rovnomasi yordamida baholandi, u to'rtta sohani o'z ichiga oladi: hissiy, ijtimoiy, jismoniy va ruhiy farovonlik. Natijalar shuni ko'rsatdiki, tadqiqot guruhidagi ayollar nazorat guruhiga nisbatan hayot sifatining barcha sohalarida sezilarli darajada yuqori ko'rsatkichlarga ega (p <0,001). Shunday qilib, tug'ilishni saqlash dasturlari ushbu bemorlarning hayot sifatiga ijobiy ta'sir ko'rsatib, ularni saraton kasalliklarini davolashga kompleks yondashuvda amalga oshirish zarurligini ta'kidlaydi.
Библиографические ссылки
Boivin, J, Takefman, J, Braverman, A. (2011). The fertility quality of life (FertiQoL) tool: development and general psychometric properties. Human Reproduction, 26(8), 2084–2091.
Nurudeen S.K., Douglas N.C., Mahany E.L., Sauer M.V., Choi J.M. Fertility preservation decisions among newly diagnosed oncology patients: A single-center experience. Am. J. Clin. Oncol. 2016;39:154–159.
Balachandren N., Davies M. Fertility, ovarian reserve and cancer. Maturitas. 2017;105:64–68.
Stroud J.S., Mutch D., Rader J., Powell M., Thaker P.H., Grigsby P.W. Effects of cancer treatment on ovarian function. Fertil. Steril. 2009;92:417–427.
Mahajan N. Fertility preservation in female cancer patients: An overview. J. Hum. Reprod. Sci. 2015;8:3–13.
Arbyn M., Weiderpass E., Bruni L., de Sanjosé S., Saraiya M., Ferlay J., Bray F. Estimates of incidence and mortality of cervical cancer in 2018: A worldwide analysis. Lancet Glob. Health. 2020;8:e191–e203.
Alimjanovich , R. Z., Maxammatkulovich , R. N., & Khikmatovich , K. K. (2022). Age Features of the Prevalence of Prostate Cancer in Uzbekistan. Central Asian Journal of Medical and Natural Science, 3(5), 154-157. Retrieved from
Rizaev Jasur , Rakhimov Nodir , Kodyrov Khamidullo , Shakhanova Shakhnoza . Study of prostate cancer death by regions of the republic of Uzbekistan.Journal of Biomedicine and Practice. 2022, vol . 7, issue 5, pp.202-210
Nodir RM, Shaxnoza SS, Farhod R. Development of new approaches in the treatment of metastatic renal cell carcinoma //Journal of research in health science. – 2020. – T. 5. – no. 4. – pp. 82-95.
ShSh Shakhanova , NM Rakhimov. Multimodal approach to the treatment of multiple osteogenic metastases of kidney and prostate cancer . Clinical and Experimental Oncology 2020, No. 4 Page 50-56.
Guillon S., Popescu N., Phelippeau J., Koskas M. A systematic review and meta-analysis of prognostic factors for remission in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma. Int. J. Gynaecol. Obstet. 2019;146:277–288.
